The two main constraints impeding the expansion of the global Dry Eye Syndrome Market are the delay in the drug approval procedure and the shortage of qualified ophthalmologists. Testing organisations' strict drug approval procedures cause delays in the introduction of new medications to the market. Patients in primary healthcare facilities in developing countries sometimes are unaware of the signs and symptoms of dry eye disorders, which hinders the market's expansion for dry eye condition.
The absence of tears or lubrication in the eyes is known as Dry Eye Syndrome. When the eye does not generate enough tears or when the tears leave the eyes too rapidly, it mostly happens. It also goes by the name of keratoconjunctivitis sicca (KCS), and it affects 5 to 30% of people worldwide. This issue may have a number of underlying reasons. Use of contact lenses, meibomian gland dysfunction, pregnancy, Sjögren syndrome, vitamin A deficiency, omega-3 fatty acid deficiency, and LASIK eye surgery are a few of the significant causes. Also contributing to the issue may be the use of antihistamines, some blood pressure drugs, hormone replacement treatment, and antidepressants.
Source Link- https://cmi-latestreportorientedblogs.blogspot.com/2023/01/the-rising-prevalence-of-dry-eye-to.html
